Anpario plc (FRA:KI9A)

Market Cap	133.26M +24.0%
Revenue (ttm)	51.24M +34.3%
Net Income	6.00M +70.4%
EPS	0.35 +65.5%
Shares Out	n/a
PE Ratio	22.20
Forward PE	17.63
Dividend	0.13 (2.17%)
Ex-Dividend Date	Nov 13, 2025

Volume	2
Average Volume	295
Open	6.20
Previous Close	7.00
Day's Range	6.15 - 6.25
52-Week Range	3.50 - 7.00
Beta	n/a
RSI	51.70
Earnings Date	Mar 31, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Food and Kindred Products
• Founded: 1996
• Employees: 157
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KI9A

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.

Financial numbers in GBP